Mandate

Vinge advises Altor in connection with its acquisition of a significant minority stake in Marshall Group AB (publ)

Vinge advises the Altor Funds (“Altor”) in connection with its acquisition of a significant minority stake in Marshall Group AB (publ) (“Marshall”) from Varenne AB, Varenne Invest I AB, Zenith Venture Capital I AB, Zenith Venture Capital III AB as well as a large number of smaller investors.

Marshall is an audio-, tech- and design powerhouse, active in more than 90 markets, with approximately SEK four billion of revenues and employs approximately 800 people across eight locations globally.

Vinge’s team consisted mainly of Christina Kokko, Johanna Wiberg and Viktor Lennartsson (M&A), David Olander (Competition), Victor Ericsson and Emelie Svanberg (Tax).

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025